Insulet Corp

PODD Nasdaq SEC CIK 1145197
Follow Insulet Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $842M +19.2% vs same quarter last year
Net income $141.1M +61.1% vs same quarter last year
EPS, diluted $2.03 +63.7% vs same quarter last year
Operating cash flow $123.5M −1.8% vs same quarter last year
Revenue by quarter
$597.5M
$569M
$649.1M
$706.3M
$783.8M
$761.7M
$801.7M
$842M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$1B$0$1B$2B$3BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$2.7B$247.1M
FY24$2.1B$418.3M
FY23$1.7B$206.3M
FY22$1.1B$4.6M
FY21$1B$16.8M
FY20$904.4M$6.8M
FY19$738.2M$11.6M
FY18$563.8M$3.3M
FY17$463.8M−$26.8M
FY16$367M−$28.9M
FY15$263.9M−$73.5M
FY14$231.3M−$51.5M
FY13$185.1M−$45M
FY12$211.4M−$51.9M
FY11$152.3M−$45.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%0%50%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2571.6%17.5%9.1%
FY2469.8%14.9%20.2%
FY2368.3%13%12.2%
FY2276.3%3.6%0.4%
FY2172.3%12.1%1.6%
FY2064.4%5.7%0.8%
FY1965.1%6.8%1.6%
FY1865.7%4.9%0.6%
FY1759.8%−1.6%−5.8%
FY1657.5%−2.9%−7.9%
FY1550.5%−18.5%−27.9%
FY1455%−3.8%−22.3%
FY1348.5%−14.4%−24.3%
FY1243.7%−17%−24.5%
FY1143.8%−27.9%−30.1%
Free cash flowOperating cash flow minus capital expenditure
−$200M$0$200M$400MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$377.7M
FY24$305.3M
FY23$70.1M
FY22−$3.9M
FY21−$180M
FY20−$45M
FY19−$65.3M
FY18−$121.5M
FY17−$32.5M
FY16−$6.2M
FY15−$23.2M
FY14−$2.6M
FY13−$4M
FY12−$40.1M
FY11−$36.6M
Returned to shareholdersDividends paid and shares bought back
$0$20M$40M$60MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$59.6M
FY24$0
FY23$0
FY22-
FY21-
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Insulet
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearInsuletHealthcare median
FY259.1%−30.6%
FY2420.2%−47%
FY2312.2%−58%
FY220.4%−80.4%
FY211.6%−71.9%
FY200.8%−62.2%
FY191.6%−46.3%
FY180.6%−49.6%
FY17−5.8%−45.9%
FY16−7.9%−36%
FY15−27.9%−38.4%
FY14−22.3%−35.5%
FY13−24.3%−37.1%
FY12−24.5%−29.1%
FY11−30.1%−27.9%